Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
批准号:
7648081
负责人:
EMMANUEL O AKALA
金额:
$11.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2011-06-30
关键词:
2-hydroxyethyl methacrylateAffectAmericanAntineoplastic AgentsBeliefBiocompatibleBiologicalBiological AssayBiological MarkersBreastBreast CarcinomaCancer DetectionCardiovascular DiseasesCell DeathCell LineCell SurvivalCellsChemicalsChemotherapy-Oncologic ProcedureClinicColorectal CancerCrosslinkerDevelopmentDoseDrug CarriersDrug CombinationsDrug ControlsDrug Delivery SystemsDrug EffluxDrug resistanceEndocytosisEthylene GlycolsEvaluationFDA approvedFutureGenderGlassGoalsHealthHeterogeneityHormonesHumanHydrolysisImageImmuneIn VitroInfectionInheritedIntrinsic factorIonizing radiationLifeLigandsLungMalignant Epithelial CellMalignant NeoplasmsMeasurementMetabolismMolecular WeightMorphologyMutationNanospherePaclitaxelParticle SizePatientsPharmaceutical PreparationsPropertyProstatePumpRadiationReportingResearchResearch Project GrantsResistanceScanning Electron MicroscopyScreening for cancerSiteSolutionsSpectroscopy, Fourier Transform InfraredSurfaceSystemTemperatureTimeTobacco smokingTransmission Electron MicroscopyTumor BurdenUltraviolet RaysUnited StatesVirus DiseasesWaterbasecancer cellcancer diagnosiscancer therapycarcinogenesiscell growthcontrolled releasecopolymercrosslinkcytotoxicitydesignefflux pumpethylene glycolin vivokillingsmeltingmortalitynanoparticleneoplastic cellpoly(L-lactide)poly(lactic acid)poly(lactide)receptor mediated endocytosistargeted deliverytraffickinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The importance of the problem of cancer is shown by the report which indicates that more than 1.3 million cases of cancer are diagnosed annually and that cancer claims an estimated 570,280 lives in the United States each year. It is believed that cancer is second only to cardiovascular diseases as a cause of mortality among Americans. The most common cancers in United States are prostate, breast, lung and colorectal cancers. Thus cancer does not discriminate on the basis of gender. Both extrinsic factors [e.g., tobacco smoking, chemicals, drugs, hormones, radiations (such as ionizing radiations and ultraviolet light), and infections (such as viral infections)] and patient intrinsic factors (e.g., inherited metabolism mutations, hormones, and immune conditions) are believed to be important initiators of cancers.
Frantic efforts have been made over the years to identify factors affecting successful treatment of cancer: tumor burden, tumor-cell heterogeneity, drug resistance, dose intensity, and poor selectivity of the drug. Moreover, a great deal of research has been carried out to find ways and means to circumvent the problems of cancer treatment: targeted delivery of drugs to cancer, in vivo detection of cancer biomarkers, detection of cancer biomarkers ex vivo, overcoming biological barriers to the biophase (site of action), identification of potential targets and targeting moieties for anti-cancer drug delivery systems, drug combination, and the development of efficient drug carriers. There is a need for the integration of all these efforts. The development of multifunctional polymeric nanospheres for cancer therapy, which is the long-term objective of this application, could make the integration possible. The core of the nanosphere can be loaded with anti-cancer agents, imaging agent, and agents to overcome pump and non-pump resistance; targeting moieties and agents responsive to biomarkers could be tagged to the external coating made of poly(ethylene glycol). All these will achieve early detection of cancer and provide effective killing of the cancer cells. The goal of the research in this application is to initiate efforts that will make it possible to achieve the capabilities of multifunctional nanoparticles by developing paclitaxel-loaded stealth nanospheres based on biocompatible and biodegradable poly(lactic acid). Synthesis of biodegradable and biocompatible macromonomers, fabrication and characterization of paclitaxel-loaded nanopsheres and their evaluation for cell uptake and cytotoxicity in the BT-20 human breast carcinoma cell line are the focus of this proposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment
-
批准号:10411148
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2022
-
负责人:EMMANUEL O AKALA
-
依托单位:
Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment
-
批准号:10672232
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2022
-
负责人:EMMANUEL O AKALA
-
依托单位:
Administrative Supplements for Equipment Purchases for Select NIGMS_Akala
-
批准号:10793724
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2022
-
负责人:EMMANUEL O AKALA
-
依托单位:
Novel Nanotechnology Platform for Breast Cancer Treatment
-
批准号:8793606
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2015
-
负责人:EMMANUEL O AKALA
-
依托单位:
Novel Nanotechnology Platform for Breast Cancer Treatment
-
批准号:9265808
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2015
-
负责人:EMMANUEL O AKALA
-
依托单位:
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
-
批准号:7898892
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2008
-
负责人:EMMANUEL O AKALA
-
依托单位:
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
-
批准号:7341850
-
项目类别:
-
资助金额:$14.8万
-
财政年份:2008
-
负责人:EMMANUEL O AKALA
-
依托单位:
Controlled Delivery System for Naltrexone
-
批准号:6419280
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2002
-
负责人:EMMANUEL O AKALA
-
依托单位:
Controlled Delivery System for Naltrexone
-
批准号:6620594
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2002
-
负责人:EMMANUEL O AKALA
-
依托单位:
Controlled Delivery System for Naltrexone
-
批准号:6700302
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2002
-
负责人:EMMANUEL O AKALA
-
依托单位:
COLON SPECIFIC PEPTIDE (PROTEIN) DELIVERY
-
批准号:2293259
-
项目类别:
-
资助金额:$3.75万
-
财政年份:1995
-
负责人:EMMANUEL O AKALA
-
依托单位:
COLON SPECIFIC PEPTIDE (PROTEIN) DELIVERY
-
批准号:2293258
-
项目类别:
-
资助金额:$3.67万
-
财政年份:1994
-
负责人:EMMANUEL O AKALA
-
依托单位:
海外基金